Sorafenib and its derivative SC-49 sensitize hepatocellular carcinoma cells to CS-1008, a humanized anti-TNFRSF10B (DR5) antibody

British Journal of Pharmacology (2013) - Comments
pubmed: 22978563 doi: 10.1111/j.1476-5381.2012.02212.x issn: 1476-5381 issn: 0007-1188

Kuen-Feng Chen, Hui-Ling Chen, Chung-Wai Shiau, Chun-Yu Liu, Pei-Yi Chu, Wei-Tien Tai, Kimihisa Ichikawa, Pei-Jer Chen, Ann-Lii Cheng